The federal authorities is reviewing a brand new COVID-19 vaccine that has been submitted for regulatory approval.
Maryland-based Novavax quietly utilized on Friday for Well being Canada to approve its vaccine, which research have urged is efficient towards the British and South African variants of the virus.
The appliance comes lower than two weeks after Ottawa finalized an settlement with the corporate for 52 million doses of the vaccine, with an choice to buy one other 24 million.
[ Sign up for our Health IQ newsletter for the latest coronavirus updates ]
The regulatory overview additionally comes as Ottawa continues urgent the European Union on new controls on the export of vaccines from the continent.
Canada secures two new offers for potential COVID-19 vaccines
Worldwide Commerce Minister Mary Ng spoke to her European counterpart for the second time in three days on Saturday as a part of a broader effort to make sure vaccines certain for Canada is not going to be affected.
The EU’s new export controls come amid lowered shipments of the Pfizer-BioNTech vaccine due to a short lived shutdown of its plant in Belgium.
View hyperlink »
© 2021 The Canadian Press